These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38056905)

  • 21. Erythrocyte-cancer hybrid membrane-camouflaged melanin nanoparticles for enhancing photothermal therapy efficacy in tumors.
    Jiang Q; Liu Y; Guo R; Yao X; Sung S; Pang Z; Yang W
    Biomaterials; 2019 Feb; 192():292-308. PubMed ID: 30465973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Light/pH-Triggered Biomimetic Red Blood Cell Membranes Camouflaged Small Molecular Drug Assemblies for Imaging-Guided Combinational Chemo-Photothermal Therapy.
    Ye S; Wang F; Fan Z; Zhu Q; Tian H; Zhang Y; Jiang B; Hou Z; Li Y; Su G
    ACS Appl Mater Interfaces; 2019 May; 11(17):15262-15275. PubMed ID: 30964624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sequentially-targeted biomimetic nano drug system for triple-negative breast cancer ablation and lung metastasis inhibition.
    Fan J; Liu B; Long Y; Wang Z; Tong C; Wang W; You P; Liu X
    Acta Biomater; 2020 Sep; 113():554-569. PubMed ID: 32569637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hybrid membrane camouflaged copper sulfide nanoparticles for photothermal-chemotherapy of hepatocellular carcinoma.
    Ji B; Cai H; Yang Y; Peng F; Song M; Sun K; Yan F; Liu Y
    Acta Biomater; 2020 Jul; 111():363-372. PubMed ID: 32434082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential tumor cell targeting of anti-HER2 (Herceptin) and anti-CD20 (Mabthera) coupled nanoparticles.
    Cirstoiu-Hapca A; Bossy-Nobs L; Buchegger F; Gurny R; Delie F
    Int J Pharm; 2007 Mar; 331(2):190-6. PubMed ID: 17196347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene Reprogramming Armed Macrophage Membrane-Camouflaged Nanoplatform Enhances Bionic Targeted Drug Delivery to Solid Tumor for Synergistic Therapy.
    Ning P; Yao H; Du F; Yuan J; Xia Y; Yang P; Chen X; Rao Z; Wang X
    Mol Pharm; 2023 May; 20(5):2362-2375. PubMed ID: 36989419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benefit of anti-HER2-coated paclitaxel-loaded immuno-nanoparticles in the treatment of disseminated ovarian cancer: Therapeutic efficacy and biodistribution in mice.
    Cirstoiu-Hapca A; Buchegger F; Lange N; Bossy L; Gurny R; Delie F
    J Control Release; 2010 Jun; 144(3):324-31. PubMed ID: 20219607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted Drug Delivery and Image-Guided Therapy of Heterogeneous Ovarian Cancer Using HER2-Targeted Theranostic Nanoparticles.
    Satpathy M; Wang L; Zielinski RJ; Qian W; Wang YA; Mohs AM; Kairdolf BA; Ji X; Capala J; Lipowska M; Nie S; Mao H; Yang L
    Theranostics; 2019; 9(3):778-795. PubMed ID: 30809308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet-Tumor Cell Hybrid Membrane-Camouflaged Nanoparticles for Enhancing Therapy Efficacy in Glioma.
    Wu L; Li Q; Deng J; Shen J; Xu W; Yang W; Chen B; Du Y; Zhang W; Ge F; Lei S; Li K; Wang Z
    Int J Nanomedicine; 2021; 16():8433-8446. PubMed ID: 35002237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolonged blood circulation outperforms active targeting for nanocarriers-mediated enhanced hepatocellular carcinoma therapy in vivo.
    Wang YQ; Huang C; Ye PJ; Long JR; Xu CH; Liu Y; Ling XL; Lv SY; He DX; Wei H; Yu CY
    J Control Release; 2022 Jul; 347():400-413. PubMed ID: 35577150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioinspired red blood cell membrane-encapsulated biomimetic nanoconstructs for synergistic and efficacious chemo-photothermal therapy.
    Wang P; Jiang F; Chen B; Tang H; Zeng X; Cai D; Zhu M; Long R; Yang D; Kankala RK; Wang S; Liu Y
    Colloids Surf B Biointerfaces; 2020 May; 189():110842. PubMed ID: 32058253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigation of antitumor activities of trastuzumab delivered by PLGA nanoparticles.
    Colzani B; Pandolfi L; Hoti A; Iovene PA; Natalello A; Avvakumova S; Colombo M; Prosperi D
    Int J Nanomedicine; 2018; 13():957-973. PubMed ID: 29491709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multifunctional tumor-targeted PLGA nanoparticles delivering Pt(IV)/siBIRC5 for US/MRI imaging and overcoming ovarian cancer resistance.
    Zhang Y; Dong Y; Fu H; Huang H; Wu Z; Zhao M; Yang X; Guo Q; Duan Y; Sun Y
    Biomaterials; 2021 Feb; 269():120478. PubMed ID: 33213862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Redox-sensitive carrier-free nanoparticles self-assembled by disulfide-linked paclitaxel-tetramethylpyrazine conjugate for combination cancer chemotherapy.
    Zou L; Liu X; Li J; Li W; Zhang L; Fu C; Zhang J; Gu Z
    Theranostics; 2021; 11(9):4171-4186. PubMed ID: 33754055
    [No Abstract]   [Full Text] [Related]  

  • 35. Strengthening Gastric Cancer Therapy by Trastuzumab-Conjugated Nanoparticles with Simultaneous Encapsulation of Anti-MiR-21 and 5-Fluorouridine.
    Hu N; Yin JF; Ji Z; Hong Y; Wu P; Bian B; Song Z; Li R; Liu Q; Wu F
    Cell Physiol Biochem; 2017; 44(6):2158-2173. PubMed ID: 29241186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eradication of growth of HER2-positive ovarian cancer with trastuzumab-DM1, an antibody-cytotoxic drug conjugate in mouse xenograft model.
    Yu L; Wang Y; Yao Y; Li W; Lai Q; Li J; Zhou Y; Kang T; Xie Y; Wu Y; Chen X; Yi C; Gou L; Yang J
    Int J Gynecol Cancer; 2014 Sep; 24(7):1158-64. PubMed ID: 24987913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics and in vitro/in vivo antitumor efficacy of aptamer-targeted Ecoflex
    Ghassami E; Varshosaz J; Jahanian-Najafabadi A; Minaiyan M; Rajabi P; Hayati E
    Int J Nanomedicine; 2018; 13():493-504. PubMed ID: 29416331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antisense LNA-loaded nanoparticles of star-shaped glucose-core PCL-PEG copolymer for enhanced inhibition of oncomiR-214 and nucleolin-mediated therapy of cisplatin-resistant ovarian cancer cells.
    Vandghanooni S; Eskandani M; Barar J; Omidi Y
    Int J Pharm; 2020 Jan; 573():118729. PubMed ID: 31705975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Starvation-amplified CO generation for enhanced cancer therapy via an erythrocyte membrane-biomimetic gas nanofactory.
    Wang Y; Liu Z; Wang H; Meng Z; Wang Y; Miao W; Li X; Ren H
    Acta Biomater; 2019 Jul; 92():241-253. PubMed ID: 31078766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual-targeting hybrid nanoparticles for the delivery of SN38 to Her2 and CD44 overexpressed human gastric cancer.
    Yang Z; Luo H; Cao Z; Chen Y; Gao J; Li Y; Jiang Q; Xu R; Liu J
    Nanoscale; 2016 Jun; 8(22):11543-58. PubMed ID: 27203688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.